메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Oriental Culture Holding LTD Announces Special Cash Dividend Plan to Reward Shareholders on Fifth Anniversary of Listing

Nasdaq: OCG NEW YORK, Jan. 12, 2026 -- Oriental Culture Holding LTD (Nasdaq: OCG) announced today that its Board of Directors has approved a special cash dividend plan to celebrate the company's fifth anniversary of listing on Nasdaq and reward shareholders for their long-term support. The specific dividend details are as follows: Dividend Type: Special Cash Dividend Eligible Shareholders: Shareholders of record as of January 22, 2026 Dividend Amount: US$0.05 per share (based on shares outstanding as of the record date of January 22, 2026) Payment Date: February
- 황정호 기자
- 2026-01-12 21:55
Oriental Culture Holding LTD、上場5周年を記念し、株主還元として特別現金配当計画を発表

Nasdaq： OCG ニューヨーク、2026年1月12日 -- Oriental Culture Holding LTD（Nasdaq：OCG）は本日、Nasdaq上場5周年を記念し、長期にわたる株主の支援に感謝の意を示すため、特別現金配当計画を取締役会が承認したと発表しました。配当の詳細は以下のとおりです。配当の種類：特別現金配当対象株主：2026年1月22日時点で株主名簿に記載されている株主配当金額：1株当たり0.05米ドル（2026年1月22日時点の発行済み株式数に基づいて算定）支払日：2026年2月9日 OCG CEOのShao Yiは次のように述べています。「当社は、事業の継続的な運営および成長に必要な資金を確保したうえで、過去数年間に積み上げてきた現金準備金の一部を配当として株主の皆様に還元することを決定しました。これは、株主の皆様からの支援に応え、当社の成長の成果を共有するという当社の姿勢を示すものです。今回の配当は、株主の皆様と歩んできた5年間のパートナーシップに対する心からの感謝の意を表しています。私たちは、事業の成長に取り組みながら、株主の皆様へ直接還元していくことが、長期的な企業価値の向上につながると考えています。」この配当計画は、2026年1月8日に取
- 황정호 기자
- 2026-01-12 21:55
오리엔탈 컬처 홀딩, 나스닥 상장 5주년 맞아 주주 보상 위한 특별 현금 배당 계획 발표

Nasdaq: OCG 뉴욕 2026년 1월 12일 -- 1월 12일 오리엔탈 컬처 홀딩(Oriental Culture Holding LTD, Nasdaq: OCG)이 나스닥 상장 5주년을 기념하고 오랫동안 회사를 지지한 주주들에게 보답하기 위해 마련한 특별 현금 배당 계획에 대해 이사회가 승인했다고 발표했다. 구체적인 배당 내용은 다음과 같다. 배당 유형: 특별 현금 배당 배당 기준일: 2026년 1월 22일 기준 주주 배당 금액: 주당 미화 0.05달러(2026년 1월 22일 기준 발행 주식 수 기준) 지급일: 2026년 2월 9일 오리엔탈 컬처 홀딩의 이샤오(Shao Yi) 최고경영자(CEO)는 "지속적인 운영과 성장을 위한 필수 자금을 확보한 후, 당사는 수년간 축적한 현금 보유분의 일부를 배당 형태로 주주들에게 환원하기로 결정했다. 이는 주주들의 성원에 보답하고 회사의 성장 성과를 함께 나누겠다는 우리의 의지를 반영한다. 이번 배당을 통해 오리엔탈 컬처 홀딩은 지난 5년간 함께해 준 주주들에게 진심 어린 감사를 표현하고자 한다. 우리는 적극적인 사업 확장과 동시에, 장기적
- 황정호 기자
- 2026-01-12 21:55
BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions

[ 메디채널 김갑성 기자 ] Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology SAN ANTONIO, Jan. 12, 2026 -- Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the AI-driven Precision Oncology Solutions sector for its outstanding achievements in Technology Innovation Leadership. This recognition highlights BostonGene's consistent leadership in driving measurable outcomes, strengthening its market position, and deliverin
- 김갑성 기자
- 2026-01-12 21:00
Major global health grant awarded to Oktopi to accelerate equitable medicine development capability worldwide.

MELBOURNE, Australia, Jan. 12, 2026 -- Oktopi has been awarded a significant grant from the Gates Foundation to advance global access to high-quality medicine development expertise, with a particular focus on supporting innovators in low- and middle-income countries (LMICs). This funding will enable Oktopi to build and expand its AI-informed knowledge and workflow engine, bringing best-practice to the critical decisions in developing medicines. The engine integrates expert-derived taxonomies, evidence expectations, and decision pathways to increase efficiency and the probability of su
- 김갑성 기자
- 2026-01-12 21:00
Xi'an Kicks Off 2026 Chang'an Lantern Festival with Epic Light Spectacles to Spring

XI'AN, China, Jan. 12, 2026 -- Recently, the opening lighting ceremony of the 2026 Chang'an Lantern Festival, themed "Thousands of Lanterns Shining on Chang'an and Welcoming Spring with Horses," was grandly held in historic city of Xi'an, China. The Festival, which used to open for Spring Festival and has been brought forward this year, blends the city's millennium-old cultural heritage with modern spectacular lighting to unfold a splendid 96-day lantern showcase spanning the three festivals of New Year, Spring Festival, and Lantern Festival, recreating the Tang Dynas
- 김장윤(JASON KIM) 기자
- 2026-01-12 20:59
XTransfer Debuts at the CES in Vegas

Accelerating Expansion into the U.S. Market to Empower Cross-Border Payments in China–U.S. Trade LAS VEGAS, Jan. 12, 2026 -- XTransfer, the world's leading B2B cross-border trade payment platform, made its debut as an exhibitor at the Consumer Electronics Show (CES 2026) in Las Vegas. This appearance marks XTransfer's acceleration into the North and South American markets and its commitment to providing Chinese and U.S. foreign trade enterprises with secure, compliant, and efficient cross-border payment solutions, facilitating smoother global trade fund flows. As
- 황정호 기자
- 2026-01-12 20:48
Apex AI brings global automation capability to Australia's scaling startups

SYDNEY, Jan. 12, 2026 -- Apex AI, the AI-automation capability firm from Roar Global, has expanded its delivery network in Australia to help high-growth founders and operators access certified automation capability faster, and at a level of quality and reliability that traditional hiring channels cannot match. With AI and workflow automation now critical to productivity, Australian companies are facing a shortage of specialists who can design, build, and maintain the systems that drive scale. Apex AI addresses this gap by sourcing top automation engineers from Asian hub
- 황정호 기자
- 2026-01-12 18:59
Infosys and ATP Unveil 'Ally', an AI Chatbot to Elevate Fan Experience, and Announce Extension of Partnership Through 2028

Ally, powered by Infosys Topaz™, will further boost the tennis experience with humanized, intelligent fan interactions BENGALURU, India, Jan. 12, 2026 -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, and ATP, global governing body of men's professional tennis, today announced the launch of Ally, an AI-powered chatbot, to further enhance fan engagement and bring the tennis community closer to the sport. Building on their decade-long relationship, Infosys and ATP also announced an extension of their partnership t
- 황정호 기자
- 2026-01-12 18:52
Novo Nordisk's GLP‑1 RA--A Modern Treatment for Obesity Management--is Linked to Lower Household Spending on Alcohol and Tobacco

[ 메디채널 김갑성 기자 ] Real-world data analysis suggests that families with at least one member using Novo Nordisk's GLP‑1 RA for weight management tend to reduce spending on alcohol and cigarettes. JAKARTA, Indonesia, Jan. 12, 2026 -- At the international scientific congress ObesityWeek® held late last year in Atlanta, United States, Novo Nordisk presented findings from a real-world analysis of grocery spending data from more than 200,000 households.[1] The analysis found that households with at least one person using Novo Nordisk's GLP‑1 RA for weight management showed a year-on-year
- 김갑성 기자
- 2026-01-12 18:29

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2026-01-15_THU

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 15일 15시 20분